Psyence Biomedical Ltd. Common Shares
Save
17.01M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates.

Similar securities

Based on sector and market capitalization

Report issue